AI In Remote Patient Monitoring Market Size And Forecast To 2040 By Component, Application, End-User, And Region Predictive Care Drives 23.1% CAGR To $61.40 Billion

(MENAFN- GlobeNewsWire - Nasdaq) AI-driven predictive monitoring, adherence tools and wearable integration enable earlier interventions, fewer readmissions, lower costs and scalable value-based care.

Dublin, Oct. 22, 2026 (GLOBE NEWSWIRE) -- "AI in Remote Patient Monitoring Market, till 2040: Distribution by Type of Component, Application Area, Type of End-User, and Key Geographical Regions: Industry Trends and Global Forecasts" has been added to ResearchAndMarkets.com's offering.

The global AI in remote patient monitoring market is projected to expand from USD 3.35 billion in the current year to USD 61.40 billion by 2040, representing a CAGR of 23.1% during the forecast period. Growth is being supported by rising chronic disease prevalence, aging populations, wider telemedicine adoption, advances in connected medical devices, and increasing demand for continuous care outside traditional clinical settings.

AI-enabled remote patient monitoring platforms combine wearable devices, sensors, mobile applications, electronic health records, and connected healthcare systems to collect and analyze real-time patient data. Machine learning algorithms identify anomalies, assess risk, anticipate potential health deterioration, and generate actionable alerts for healthcare professionals. Applications include cardiovascular monitoring, diabetes management, respiratory care, wellness improvement, medication adherence, remote wound assessment, and post-acute care.

Strategic Impact of AI on Medication Adherence

Medication non-adherence remains a major barrier to treatment effectiveness and cost control. AI-driven remote patient monitoring supports adherence through behavioral analytics, continuous oversight, and personalized interventions. Algorithms can evaluate patient engagement patterns, identify the likelihood of missed doses, and deliver reminders aligned with individual schedules and preferences.

Integration with electronic health records and wearable devices enables real-time adherence monitoring and timely feedback for patients and healthcare providers. AI-powered engagement tools can also deliver relevant educational content, address misconceptions, and encourage sustained behavioral change. These capabilities may improve treatment outcomes while reducing avoidable complications and healthcare utilization.

Technology Breakthroughs Supporting Market Expansion

Innovation in wearable biosensors, IoT connectivity, edge computing, predictive analytics, generative AI, natural language processing, and computer vision is accelerating the development of advanced remote patient monitoring solutions. Multi-parameter wearables can monitor heart rate, glucose, oxygen levels, activity patterns, UV exposure, and sweat biomarkers, while predictive models analyze continuous data to forecast cardiac incidents, hospital readmissions, and other critical events.

Generative AI and large language models are supporting automated clinical documentation and more efficient processing of unstructured healthcare data. AI-powered virtual assistants provide personalized medication reminders, patient education, and mental health support. Together, these technologies are shifting care delivery from reactive treatment toward predictive and preventive intervention while helping reduce administrative burdens for clinicians.

Key AI in Remote Patient Monitoring Market Drivers

• Increasing prevalence of cardiovascular disease, diabetes, respiratory disorders, and other chronic conditions
• Growing demand for continuous health surveillance among aging populations
• Greater adoption of telemedicine and home healthcare services following the COVID-19 pandemic
• Advances in wearable sensors, IoT-enabled devices, cloud platforms, and edge computing
• Demand for early detection, personalized interventions, and lower hospital readmission rates
• Expansion of reimbursement policies supporting remote patient monitoring services
• Healthcare industry focus on scalable, value-based care delivery

Competitive Landscape

The AI in remote patient monitoring market includes major medical technology companies, healthcare organizations, pharmaceutical businesses, technology providers, and specialized startups. Medtronic, ResMed, GE HealthCare, Roche, Dexcom, and Abbott maintain prominent positions through platforms supporting chronic disease management, predictive modeling, and wearable integration.

BioIntelliSense, Biofourmis, and AliveCor are among the emerging companies developing specialized capabilities in ambient monitoring, vital signs prediction, cardiovascular assessment, and post-acute care. Market participants also use cloud ecosystems from AWS and Microsoft Azure to support data processing, interoperability, and scalable deployment. Competition is increasingly centered on clinical accuracy, real-time analytics, patient engagement, platform integration, regulatory compliance, and measurable care outcomes.

Emerging Industry Trends

Hyper-personalized predictive analytics is becoming a defining trend across the market. Machine learning systems can establish individualized health baselines, identify deviations, and estimate the likelihood of adverse events. The integration of AI platforms with connected biosensors supports continuous monitoring and proactive intervention for cardiovascular diseases, diabetes, and other chronic conditions.

Additional trends include growing use of cloud-based software, AI-powered virtual assistants, automated clinical workflows, and patient engagement tools. Expanding reimbursement coverage and increased healthcare investment in digital infrastructure are also improving the commercial environment for remote patient monitoring providers.

Regional Market Outlook

North America currently accounts for a significant share of the AI in remote patient monitoring market. The region benefits from advanced healthcare infrastructure, high digital health adoption, substantial AI investment, and a large population requiring chronic disease management. Medicare and private insurer reimbursement policies support broader deployment of remote monitoring programs. Partnerships among technology companies, healthcare providers, research institutions, and medical device developers in the US and Canada are further accelerating adoption.

The report also evaluates market opportunities across Europe, Asia, Latin America, the Middle East and North Africa, and the Rest of the World. Country-level coverage includes major healthcare markets such as China, India, Japan, Germany, France, the UK, Brazil, Saudi Arabia, and the UAE.

Market Segmentation

The report segments the market by component, application area, end-user, and geography.

• Component: Devices, software, and services
• Application area: Cardiovascular disorders, wellness improvement, diabetes management, respiratory monitoring, and other applications
• End-user: Healthcare providers, diagnostic centers, home healthcare providers, pharmaceutical & biotechnology companies, and other organizations
• Geography: North America, Europe, Asia, Latin America, Middle East and North Africa, and Rest of the World

Report Coverage and Strategic Value

The report provides market sizing, revenue forecasts, segment-level opportunity analysis, company benchmarking, competitive intelligence, company profiles, megatrend evaluation, recent development tracking, and SWOT analysis. It examines company establishment dates, workforce size, headquarters, ownership structures, product portfolios, financial information, management teams, business segments, and recent strategic activity.

Key topics include current and future market size, leading companies, growth drivers, partnership and funding trends, regional growth potential, and the distribution of commercial opportunities across major segments. Ecosystem analysis covers partnerships, funding, patent activity, growth hotspots, and underserved market areas.

Industry interviews and expert surveys support the assessment of market trends and strategic developments. Decision-ready deliverables include Porter's Five Forces analysis, value chain analysis, SWOT frameworks, Excel dashboards, slide packs, customization support, interactive walkthroughs with the research team, and updates for report versions older than 6-12 months.

Key Attributes:

Report Attribute	Details
No. of Pages	176
Forecast Period	2026 - 2040
Estimated Market Value (USD) in 2026	$3.35 Billion
Forecasted Market Value (USD) by 2040	$61.4 Billion
Compound Annual Growth Rate	23.1%
Regions Covered	Global

Key Topics Covered:

SECTION I: REPORT OVERVIEW
1. PREFACE
1.1. Introduction
1.2. Market Share Insights
1.3. Key Market Insights
1.4. Report Coverage
1.5. Key Questions Answered
1.6. Chapter Outlines
2. RESEARCH METHODOLOGY
2.1. Chapter Overview
2.2. Research Assumptions
2.3. Database Building
2.3.1. Data Collection
2.3.2. Data Validation
2.3.3. Data Analysis
2.4. Project Methodology
2.4.1. Secondary Research
2.4.1.1. Annual Reports
2.4.1.2. Academic Research Papers
2.4.1.3. Company Websites
2.4.1.4. Investor Presentations
2.4.1.5. Regulatory Filings
2.4.1.6. White Papers
2.4.1.7. Industry Publications
2.4.1.8. Conferences and Seminars
2.4.1.9. Government Portals
2.4.1.10. Media and Press Releases
2.4.1.11. Newsletters
2.4.1.12. Industry Databases
2.4.1.13. Proprietary Databases
2.4.1.14. Paid Databases and Sources
2.4.1.15. Social Media Portals
2.4.1.16. Other Secondary Sources
2.4.2. Primary Research
2.4.2.1. Introduction
2.4.2.2. Types
2.4.2.2.1. Qualitative
2.4.2.2.2. Quantitative
2.4.2.3. Advantages
2.4.2.4. Techniques
2.4.2.4.1. Interviews
2.4.2.4.2. Surveys
2.4.2.4.3. Focus Groups
2.4.2.4.4. Observational Research
2.4.2.4.5. Social Media Interactions
2.4.2.5. Stakeholders
2.4.2.5.1. Company Executives (CXOs)
2.4.2.5.2. Board of Directors
2.4.2.5.3. Company Presidents and Vice Presidents
2.4.2.5.4. Key Opinion Leaders
2.4.2.5.5. Research and Development Heads
2.4.2.5.6. Technical Experts
2.4.2.5.7. Subject Matter Experts
2.4.2.5.8. Scientists
2.4.2.5.9. Doctors and Other Healthcare Providers
2.4.2.6. Ethics and Integrity
2.4.2.6.1. Research Ethics
2.4.2.6.2. Data Integrity
2.4.3. Analytical Tools and Databases
3. MARKET DYNAMICS
3.1. Forecast Methodology
3.1.1. Top-Down Approach
3.1.2. Bottom-Up Approach
3.1.3. Hybrid Approach
3.2. Market Assessment Framework
3.2.1. Total Addressable Market (TAM)
3.2.2. Serviceable Addressable Market (SAM)
3.2.3. Serviceable Obtainable Market (SOM)
3.2.4. Currently Acquired Market (CAM)
3.3. Forecasting Tools and Techniques
3.3.1. Qualitative Forecasting
3.3.2. Correlation
3.3.3. Regression
3.3.4. Time Series Analysis
3.3.5. Extrapolation
3.3.6. Convergence
3.3.7. Forecast Error Analysis
3.3.8. Data Visualization
3.3.9. Scenario Planning
3.3.10. Sensitivity Analysis
3.4. Key Considerations
3.4.1. Demographics
3.4.2. Market Access
3.4.3. Reimbursement Scenarios
3.4.4. Industry Consolidation
3.5. Robust Quality Control
3.6. Key Market Segmentations
3.7. Limitations
4. MACRO-ECONOMIC INDICATORS
4.1. Chapter Overview
4.2. Market Dynamics
4.2.1. Time Period
4.2.1.1. Historical Trends
4.2.1.2. Current and Forecasted Estimates
4.2.2. Currency Coverage
4.2.2.1. Overview of Major Currencies Affecting the Market
4.2.2.2. Impact of Currency Fluctuations on the Industry
4.2.3. Foreign Exchange Impact
4.2.3.1. Evaluation of Foreign Exchange Rates and Their Impact on Market
4.2.3.2. Strategies for Mitigating Foreign Exchange Risk
4.2.4. Recession
4.2.4.1. Historical Analysis of Past Recessions and Lessons Learnt
4.2.4.2. Assessment of Current Economic Conditions and Potential Impact on the Market
4.2.5. Inflation
4.2.5.1. Measurement and Analysis of Inflationary Pressures in the Economy
4.2.5.2. Potential Impact of Inflation on the Market Evolution
4.2.6. Interest Rates
4.2.6.1. Overview of Interest Rates and Their Impact on the Market
4.2.6.2. Strategies for Managing Interest Rate Risk
4.2.7. Commodity Flow Analysis
4.2.7.1. Type of Commodity
4.2.7.2. Origins and Destinations
4.2.7.3. Values and Weights
4.2.7.4. Modes of Transportation
4.2.8. Global Trade Dynamics
4.2.8.1. Import Scenario
4.2.8.2. Export Scenario
4.2.9. War Impact Analysis
4.2.9.1. Russian-Ukraine War
4.2.9.2. Israel-Hamas War
4.2.10. COVID Impact / Related Factors
4.2.10.1. Global Economic Impact
4.2.10.2. Industry-specific Impact
4.2.10.3. Government Response and Stimulus Measures
4.2.10.4. Future Outlook and Adaptation Strategies
4.2.11. Other Indicators
4.2.11.1. Fiscal Policy
4.2.11.2. Consumer Spending
4.2.11.3. Gross Domestic Product (GDP)
4.2.11.4. Employment
4.2.11.5. Taxes
4.2.11.6. R&D Innovation
4.2.11.7. Stock Market Performance
4.2.11.8. Supply Chain
4.2.11.9. Cross-Border Dynamics
SECTION II: QUALITATIVE INSIGHTS
5. EXECUTIVE SUMMARY
6. INTRODUCTION
6.1. Chapter Overview
6.2. Overview of AI in Remote Patient Monitoring Market
6.2.1. Historical Evolution
6.2.2. Key Applications
6.2.3. Impact on Healthcare
6.3. Future Perspective
7. REGULATORY SCENARIO
SECTION III: MARKET OVERVIEW
8. COMPREHENSIVE DATABASE OF LEADING PLAYERS
9. COMPETITIVE LANDSCAPE
9.1. Chapter Overview
9.2. AI in Remote Patient Monitoring Market: Overall Market Landscape
9.2.1. Analysis by Year of Establishment
9.2.2. Analysis by Company Size
9.2.3. Analysis by Location of Headquarters
9.2.4. Analysis by Ownership Structure
10. COMPANY COMPETITIVENESS ANALYSIS
11. STARTUP ECOSYSTEM IN THE AI IN REMOTE PATIENT MONITORING MARKET
11.1. AI in Remote Patient Monitoring Market: Market Landscape of Startups
11.1.1. Analysis by Year of Establishment
11.1.2. Analysis by Company Size
11.1.3. Analysis by Company Size and Year of Establishment
11.1.4. Analysis by Location of Headquarters
11.1.5. Analysis by Company Size and Location of Headquarters
11.1.6. Analysis by Ownership Structure
11.2. Key Findings
SECTION IV: COMPANY PROFILES
12. COMPANY PROFILES
12.1. Chapter Overview
12.2. Abbott
12.2.1. Company Overview
12.2.2. Company Mission
12.2.3. Company Footprint
12.2.4. Management Team
12.2.5. Contact Details
12.2.6. Financial Performance
12.2.7. Operating Business Segments
12.2.8. Service / Product Portfolio (project specific)
12.2.9. MOAT Analysis
12.2.10. Recent Developments and Future Outlook
12.3. BioIntelliSense
12.4. CompuGroup Medical
12.5. Dexcom
12.6. GE HealthCare
12.7. HealthSnap
12.8. Idoven
12.9. Jorie Healthcare Partners
12.10. Kakao Healthcare
12.11. Lepu Medical
12.12. Masimo
12.13. Medtronic
12.14. OMRON Healthcare
12.15. ResMed
12.16. Roche
SECTION V: MARKET TRENDS
13. MEGA TRENDS ANALYSIS
14. PATENT ANALYSIS
15. RECENT DEVELOPMENTS
15.1. Chapter Overview
15.2. Recent Funding
15.3. Recent Partnerships
15.4. Other Recent Initiatives
SECTION VI: MARKET OPPORTUNITY ANALYSIS
16. GLOBAL AI IN REMOTE PATIENT MONITORING MARKET
16.1. Chapter Overview
16.2. Key Assumptions and Methodology
16.3. Trends Disruption Impacting Market
16.4. Demand Side Trends
16.5. Supply Side Trends
16.6. Global AI in Remote Patient Monitoring Market, Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
16.7. Multivariate Scenario Analysis
16.7.1. Conservative Scenario
16.7.2. Optimistic Scenario
16.8. Investment Feasibility Index
16.9. Key Market Segmentations
17. MARKET OPPORTUNITIES BASED ON TYPE OF COMPONENT
17.1. Chapter Overview
17.2. Key Assumptions and Methodology
17.3. Revenue Shift Analysis
17.4. Market Movement Analysis
17.5. Penetration-Growth (P-G) Matrix
17.6. AI in Remote Patient Monitoring Market for Devices: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
17.7. AI in Remote Patient Monitoring Market for Software: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
17.8. AI in Remote Patient Monitoring Market for Services: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
17.9. Data Triangulation and Validation
17.9.1. Secondary Sources
17.9.2. Primary Sources
17.9.3. Statistical Modeling
18. MARKET OPPORTUNITIES BASED ON APPLICATION AREA
18.1. Chapter Overview
18.2. Key Assumptions and Methodology
18.3. Revenue Shift Analysis
18.4. Market Movement Analysis
18.5. Penetration-Growth (P-G) Matrix
18.6. AI in Remote Patient Monitoring Market for Cardiovascular Disorders: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
18.7. AI in Remote Patient Monitoring Market for Diabetes Management: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
18.8. AI in Remote Patient Monitoring Market for Wellness Improvement: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
18.9. AI in Remote Patient Monitoring Market for Respiratory Monitoring: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
18.10. AI in Remote Patient Monitoring Market for Others: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
18.11. Data Triangulation and Validation
18.11.1. Secondary Sources
18.11.2. Primary Sources
18.11.3. Statistical Modeling
19. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN NORTH AMERICA
19.1. Chapter Overview
19.2. Key Assumptions and Methodology
19.3. Revenue Shift Analysis
19.4. Market Movement Analysis
19.5. Penetration-Growth (P-G) Matrix
19.6. AI in Remote Patient Monitoring Market in North America: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
19.6.1. AI in Remote Patient Monitoring Market in the US: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
19.6.2. AI in Remote Patient Monitoring Market in Canada: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
19.6.3. AI in Remote Patient Monitoring Market in Mexico: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
19.6.4. AI in Remote Patient Monitoring Market in Other North American Countries: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
19.7. Data Triangulation and Validation
20. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN EUROPE
20.1. Chapter Overview
20.2. Key Assumptions and Methodology
20.3. Revenue Shift Analysis
20.4. Market Movement Analysis
20.5. Penetration-Growth (P-G) Matrix
20.6. AI in Remote Patient Monitoring Market in Europe: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.1. AI in Remote Patient Monitoring Market in Austria: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.2. AI in Remote Patient Monitoring Market in Belgium: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.3. AI in Remote Patient Monitoring Market in Denmark: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.4. AI in Remote Patient Monitoring Market in France: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.5. AI in Remote Patient Monitoring Market in Germany: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.6. AI in Remote Patient Monitoring Market in Ireland: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.7. AI in Remote Patient Monitoring Market in Italy: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.8. AI in Remote Patient Monitoring Market in Netherlands: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.9. AI in Remote Patient Monitoring Market in Norway: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.10. AI in Remote Patient Monitoring Market in Russia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.11. AI in Remote Patient Monitoring Market in Spain: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.12. AI in Remote Patient Monitoring Market in Sweden: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.13. AI in Remote Patient Monitoring Market in Switzerland: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.14. AI in Remote Patient Monitoring Market in the UK: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.6.15. AI in Remote Patient Monitoring Market in Other European Countries: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
20.7. Data Triangulation and Validation
21. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN ASIA
21.1. Chapter Overview
21.2. Key Assumptions and Methodology
21.3. Revenue Shift Analysis
21.4. Market Movement Analysis
21.5. Penetration-Growth (P-G) Matrix
21.6. AI in Remote Patient Monitoring Market in Asia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
21.6.1. AI in Remote Patient Monitoring Market in China: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
21.6.2. AI in Remote Patient Monitoring Market in India: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
21.6.3. AI in Remote Patient Monitoring Market in Japan: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
21.6.4. AI in Remote Patient Monitoring Market in Singapore: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
21.6.5. AI in Remote Patient Monitoring Market in South Korea: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
21.6.6. AI in Remote Patient Monitoring Market in Other Asian Countries: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
21.7. Data Triangulation and Validation
22. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN MIDDLE EAST AND NORTH AFRICA (MENA)
22.1. Chapter Overview
22.2. Key Assumptions and Methodology
22.3. Revenue Shift Analysis
22.4. Market Movement Analysis
22.5. Penetration-Growth (P-G) Matrix
22.6. AI in Remote Patient Monitoring Market in Middle East and North Africa (MENA): Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
22.6.1. AI in Remote Patient Monitoring Market in Egypt: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
22.6.2. AI in Remote Patient Monitoring Market in Iran: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
22.6.3. AI in Remote Patient Monitoring Market in Iraq: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
22.6.4. AI in Remote Patient Monitoring Market in Israel: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
22.6.5. AI in Remote Patient Monitoring Market in Kuwait: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
22.6.6. AI in Remote Patient Monitoring Market in Saudi Arabia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
22.6.7. AI in Remote Patient Monitoring Market in United Arab Emirates (UAE): Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
22.6.8. AI in Remote Patient Monitoring Market in Other MENA Countries: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
22.7. Data Triangulation and Validation
23. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN LATIN AMERICA
23.1. Chapter Overview
23.2. Key Assumptions and Methodology
23.3. Revenue Shift Analysis
23.4. Market Movement Analysis
23.5. Penetration-Growth (P-G) Matrix
23.6. AI in Remote Patient Monitoring Market in Latin America: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
23.6.1. AI in Remote Patient Monitoring Market in Argentina: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
23.6.2. AI in Remote Patient Monitoring Market in Brazil: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
23.6.3. AI in Remote Patient Monitoring Market in Chile: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
23.6.4. AI in Remote Patient Monitoring Market in Colombia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
23.6.5. AI in Remote Patient Monitoring Market in Venezuela: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
23.6.6. AI in Remote Patient Monitoring Market in Other Latin American Countries: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
23.7. Data Triangulation and Validation
24. MARKET OPPORTUNITIES FOR AI IN REMOTE PATIENT MONITORING IN REST OF THE WORLD
24.1. Chapter Overview
24.2. Key Assumptions and Methodology
24.3. Revenue Shift Analysis
24.4. Market Movement Analysis
24.5. Penetration-Growth (P-G) Matrix
24.6. AI in Remote Patient Monitoring Market in Rest of the World: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
24.6.1. AI in Remote Patient Monitoring Market in Australia: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
24.6.2. AI in Remote Patient Monitoring Market in New Zealand: Historical Trends (Since 2022) and Forecasted Estimates (Till 2040)
24.6.3. AI in Remote Patient Monitoring Market in Other Countries
24.7. Data Triangulation and Validation
25. MARKET CONCENTRATION ANALYSIS: DISTRIBUTION BY LEADING PLAYERS
26. ADJACENT MARKET ANALYSIS
SECTION VII: STRATEGIC TOOLS
27. KEY WINNING STRATEGIES
28. PORTER'S FIVE FORCES ANALYSIS
29. SWOT ANALYSIS
30. STRATEGIC RECOMMENDATIONS
30.1. Chapter Overview
30.2. Key Business-related Strategies
30.2.1. Research & Development
30.2.2. Product Manufacturing
30.2.3. Commercialization / Go-to-Market
30.2.4. Sales and Marketing
30.3. Key Operations-related Strategies
30.3.1. Risk Management
30.3.2. Workforce
30.3.3. Finance
30.3.4. Others
SECTION VIII: OTHER EXCLUSIVE INSIGHTS
31. INSIGHTS FROM PRIMARY RESEARCH
32. REPORT CONCLUSION
SECTION IX: APPENDIX
33. TABULATED DATA
34. LIST OF COMPANIES AND ORGANIZATIONS
35. SUBSCRIPTION SERVICES
36. AUTHOR DETAILS

A selection of companies mentioned in this report includes, but is not limited to:

• Abbott?
• BioIntelliSense?
• CompuGroup Medical?
• Dexcom?
• GE HealthCare?
• HealthSnap?
• Idoven?
• Jorie Healthcare Partners?
• Kakao Healthcare
• Lepu Medical?
• Masimo?
• Medtronic?
• OMRON Healthcare?
• ResMed
• Roche

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN22102026004107003653ID1111851088